XBI Stock Ownership Activity
SPDR S&P BIOTECH ETF 13F holders
No value investing guru has made any change to the SPDR S&P BIOTECH ETF (XBI) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying XBI now?
According to the latest SEC filing(s) SPDR S&P BIOTECH ETF (XBI) has not been purchased by any super investor.
To see more about who is investing in SPDR S&P BIOTECH ETF (XBI), please go to the XBI ownership page.
2017 Q3
(1 result)
Current price: $89.44
15.89%
Reported price*: $77.18
2017 Q2
(1 result)
Current price: $89.44
15.89%
Reported price*: $77.18
2 of 2
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.